NDC 70954-148

Pyridostigmine

Pyridostigmine Bromide Oral

Pyridostigmine is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Novitium Pharma Llc. The primary component is Pyridostigmine Bromide.

• Product ID: 70954-148_ef78ff05-8e0f-463a-88cd-ca9a01aed76a
• NDC: 70954-148
• Product Type: Human Prescription Drug
• Proprietary Name: Pyridostigmine
• Generic Name: Pyridostigmine Bromide Oral
• Dosage Form: Solution
• Route of Administration: ORAL
• Marketing Start Date: 2019-03-11
• Marketing Category: ANDA / ANDA
• Application Number: ANDA211694
• Labeler Name: Novitium Pharma LLC
• Substance Name: PYRIDOSTIGMINE BROMIDE
• Active Ingredient Strength: 60 mg/5mL
• Pharm Classes: Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 70954-148-10

473 mL in 1 BOTTLE (70954-148-10)

• Marketing Start Date: 2019-03-11
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 70954-148-10 [70954014810]

Pyridostigmine SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA211694
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2019-03-11

Drug Details

Active Ingredients

Ingredient	Strength
PYRIDOSTIGMINE BROMIDE	60 mg/5mL

OpenFDA Data

• SPL SET ID: ef78ff05-8e0f-463a-88cd-ca9a01aed76a
• Manufacturer:
  • Novitium Pharma LLC
• UNII:
  • KVI301NA53
• RxNorm Concept Unique ID - RxCUI:
  • 903843

Pharmacological Class

• Cholinesterase Inhibitor [EPC]
• Cholinesterase Inhibitors [MoA]
• Cholinesterase Inhibitor [EPC]
• Cholinesterase Inhibitors [MoA]